Navigation Links
Epeius Biotechnologies Awarded U.S. Patent for Targeted Injectable Gene Delivery In Vivo
Date:3/25/2008

SAN MARINO, Calif., March 25 /PRNewswire/ -- Epeius Biotechnologies Corporation announced today the issue of U.S. Patent No. 7,347,998 for Targeted Gene Delivery in vivo. This patent provides additional intellectual property protection for the platform of highly advanced biotechnologies embodied in the company's leading anti-cancer agent, Rexin-G. Administered clinically by simple intravenous infusion, the Epeius tumor-targeted gene delivery system enables Rexin-G to seek out and accumulate selectively in cancerous tissues and remote metastatic tumor nodules that have spread throughout the body. Rexin-G delivers it tumor-killing payload precisely where it is needed most, by targeting cancer from the inside.

*(LOGO: Send2Press.com/mediaboom/08-0325-Epeius_72dpi.jpg)

Rexin-G demonstrates profound single agent efficacy in a broad spectrum of chemotherapy refractory cancers, including pancreatic cancer, breast cancer, colon cancer, squamous cell carcinoma of larynx, uterine cancer, gastric cancer, malignant melanoma, validating Epeius Biotechnologies' in vivo targeted gene delivery platform [Int'l J Oncol, 2006, 2007].

The response rates seen with Rexin-G are unmatched by any other tumor- targeted gene delivery system. The U.S. FDA has granted Orphan Drug Status to Rexin-G based on its performance as a single therapeutic agent in treating chemotherapy refractory pancreatic cancer. Based on its exemplary record of safety and efficacy as an anti-cancer agent in a broad spectrum of chemo- resistant tumors, Rexin-G received accelerated approval for the treatment of all solid tumors by the Philippine BFAD, leading to its registration. Currently, Rexin-G is being tested as a single therapeutic agent in three separate U.S. Phase I/II Trials for recurrent or metastatic cancers of the breast or pancreas and for bone and soft tissue sarcoma respectively. Additionally, a Phase II Registration Protocol is underway for chemo-resistant osteosarcoma in Los
'/>"/>

SOURCE Epeius Biotechnologies Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit Conference in Boston MA
2. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
3. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
4. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
5. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Completion of $2,277,000 Equity Financing
6. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer
7. Amyris Biotechnologies Announces $70 Million Series B Round
8. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines
9. Maven Biotechnologies, LLC to Present at BIOCOM Investor Conference
10. Millennium Biotechnologies, Inc. Launches SURGEX(TM) the First Scientifically Validated Sports Nutritional Product Created from the Medical Markets
11. Raven biotechnologies, inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2008)...July 3 /- On June 27, 2008,GeneraMedi...ug,Administration (FDA) for its Epoprostenol for I...rostenol for Injection 1.5 mg is indicated for the...ary hypertension and pulmonary,hypertension associ...YHA,Class III and Class IV patients who do not res...
(Date:7/3/2008)...swire-FirstCall/ -- Advanced Life Sciences,Holding...any engaged in the,discovery, development and comm...eas of infection, cancer and respiratory diseases,...Microcap(R) Index after the,Russell Investment Gro...,global equity indexes on June 27, 2008., (Logo: ...
(Date:7/3/2008)...uly 3 /- Senesco,Technologi...) announced today,that it has contracted with Poly...yplus,s "in vivo-jetPEI" for systemic delivery of ...tor 5A and a plasmid of the Factor,5A gene., Sene...n vivo results,using its combination siRNA and pla...
(Date:7/3/2008)...Xinhua-- Huifeng,Bio-Pharma...B), a leading,developer and producer of plant extr...harmaceutical, nutraceutical and food production i...ion will be made available via,Standard & Poor,s M...service that enables subscribing publicly traded c...
Breaking Biology Technology:GeneraMedix Inc. Receives Approval for Epoprostenol for Injection 1.5 mg 2Advanced Life Sciences Added to Russell Microcap Index 2Advanced Life Sciences Added to Russell Microcap Index 3Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System 2Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System 3Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System 4Huifeng Bio-Pharmaceutical (HFGB) Information to Be Available Through Standard & Poor's Market Access Program 2
...ng to Madison from Chicago is being welcomed with ...rnor Jim Doyle announced earlier this week that C...om the Department of Commerce Technology Venture ...) programs to help the company purchase new equipm...,We are extremely enthusiastic to join the dynamic...
...and communications system. Image courtesy of GE He...ced that his budget will include $10 million for a...ctronic medical record (EMR) systems. , ,"I am com...eive quality health care," Doyle said. "That,s why...at will help to reduce potentially dangerous medic...
... an organization is its information, which is why ...But how much content management does your organiza...ment system (CMS) delivers many benefits to an org...ing deadlines, greater efficiency and a wider rang...rly 1,000 CMS solutions to choose from, identifyin...
...omers in 13 states, 60 percent ownership of Cingul...C was hardly just another local phone company. To ... still a regional operator that lacked overseas pu... before it was announced the company will acquire ..., SBC will simultaneously become the biggest long-...
Other Biology Technology:Doyle proposes $10M to expand use of electronic medical records 2Doyle proposes $10M to expand use of electronic medical records 3Consider the content when managing information online 2Consider the content when managing information online 3Consider the content when managing information online 4SBC and AT&T merger expands global reach for Wisconsin businesses 2SBC and AT&T merger expands global reach for Wisconsin businesses 3
(Date:7/3/2008)...ntibiotics is that, eventually, bacteria outsmart ...ne that confers such resistance, a new drug may be...ty scientists tested the new drug, called Ceftobip...tidrug-resistant Staphylococcus aureus (MRSA) bact... of staphylococcal infections worldwide, both in h...
(Date:7/2/2008)...y, Germany and the U.K. have discovered that our o...to the active ingredient in marijuana (THC), but t...hy skin. This finding on "endocannabinoids" just p...2008 print issue of, The FASEB Journal could lea...from acne to dry skin, and even skin-related tumor...
(Date:7/2/2008)...Wildlife Fund (WWF) is alarmed by the dramatic dec...pulation of Suklaphanta Wildlife Reserve in Nepal,...ities of the endangered species in the Eastern Him...opulation of between 6-14 tigers, down from 20-50 ...a low-key announcement on July 1 based on the resu...
(Date:7/2/2008)...able in German . , Metabolomics aims to determi...r a tissue. The exponents of bioinformatics analyz...al metabolomics study in healthy and diabetic mice...ted with the diabetes drug RoziglitazoneTM. Then, ...rmined in a blood plasma sample of a total of fort...
Breaking Biology News(10 mins):New antibiotic beats superbugs at their own game 2Tigers disappear from Himalayan refuge 2Healthy or diseased? 2Novavax Reports Positive Results from Preclinical Studies of its VLP based Trivalent Seasonal Influenza Vaccine Candidate 1819 1Novavax Reports Positive Results from Preclinical Studies of its VLP based Trivalent Seasonal Influenza Vaccine Candidate 1819 2Novavax Reports Positive Results from Preclinical Studies of its VLP based Trivalent Seasonal Influenza Vaccine Candidate 1819 3Smoking Drinking Cholesterol May Be Alzheimers Risk Factors 16947 1Smoking Drinking Cholesterol May Be Alzheimers Risk Factors 16947 2Smoking Drinking Cholesterol May Be Alzheimers Risk Factors 16947 3Study Shows Pine Bark Naturally Reduces Osteoarthritis 16946 1Study Shows Pine Bark Naturally Reduces Osteoarthritis 16946 2Study Shows Pine Bark Naturally Reduces Osteoarthritis 16946 3Study Shows Pine Bark Naturally Reduces Osteoarthritis 16946 4Study Shows Pine Bark Naturally Reduces Osteoarthritis 16946 5Abbott Announces HUMIRA 28R 29 28adalimumab 29 Approved in Japan for the Treatment of Rheumatoid Arthritis 16943 1Abbott Announces HUMIRA 28R 29 28adalimumab 29 Approved in Japan for the Treatment of Rheumatoid Arthritis 16943 2Abbott Announces HUMIRA 28R 29 28adalimumab 29 Approved in Japan for the Treatment of Rheumatoid Arthritis 16943 3Abbott Announces HUMIRA 28R 29 28adalimumab 29 Approved in Japan for the Treatment of Rheumatoid Arthritis 16943 4Abbott Announces HUMIRA 28R 29 28adalimumab 29 Approved in Japan for the Treatment of Rheumatoid Arthritis 16943 5Abbott Announces HUMIRA 28R 29 28adalimumab 29 Approved in Japan for the Treatment of Rheumatoid Arthritis 16943 6Abbott Announces HUMIRA 28R 29 28adalimumab 29 Approved in Japan for the Treatment of Rheumatoid Arthritis 16943 7
...rogress in understanding the basis of coral reef r...portance of a rare batfish, Platax pinnatus, in pr...reef overgrown with algae. The findings bring to l...h species, which had not been considered a signifi... doing so, the study provides insight into the poo...
...organisms living in water, the force is always aga...ed paramecium, which consistently swims harder goi...Now physicists Karine Guevorkian and James Valles ...gravity on its head and see how the creatures resp...er and live paramecia inside a high-powered electr...
..., air and water pathogens may get a lot easier and...iversity researcher and his team. , Syed Hashsham...l and Environmental Engineering and the Center for...-held device capable of detecting up to 50 microbi...s device will give us the ability to measure patho...
...rom ASM Press uses the familiar genre of the ABC b...rld of microbes. The Invisible ABCs will delight r...and spectacular selection of illustrations. Inten...ue new book will stimulate parents, teachers, libr...scinating world of microorganisms. , "We are immer...
Other Biology News:Fish species plays surprise role in aiding coral reef recovery 2Paramecia adapt their swimming to changing gravitational force 2Professors to develop hand-held pathogen testing device 2
...polyclonal antibody to the Salmonella Common Struc...a serum pool of goats immunized with different str...tive to Salmonella and recognizes all Salmonella s...for Group B and D Salmonella based upon the Kaufma...
Abgene's ALTO-8 is the first automated decapper/capper for Abgene Twist-Lock tubes.
...ilated and BR4i refrigerated multifunction centrif...ed operation at a low sound level with a large ran...ainment. Their AUTO-LOCK rotor exchange system wit...y for use within seconds. Instant rotor exchange...
Sterile, individually wrapped, 4mm Cuvettes
Biology Products: